Hikma Pharmaceutical | HIK - Sales Revenues


Hikma Pharmaceutical reported $1.69B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Almirall EUR 602.71M 55.09M Jun/2026
argenx SE USD 1.36B 240M Jun/2026
AstraZeneca USD 15.38B 90M Jun/2026
Autolus Therapeutics Ltd USD 26.22M 1.93M Mar/2026
Bayer EUR 10.87B 2.54B Jun/2026
Fresenius EUR 5.95B 210M Jun/2026
Genmab DKK 1.06B 36M Dec/2025
GlaxoSmithKline GBP 8.41B 781M Jun/2026
GRIFOLS EUR 1.87B 170M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Orion EUR 521.6M 103.9M Jun/2026
Recordati EUR 681.35M 32.07M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 11.95B 710M Jun/2026
UCB EUR 4.25B 764M Dec/2025